ITGAX
Basic information
Region (hg38): 16:31355134-31382999
Previous symbols: [ "CD11C" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGAX gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 67 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 67 | 12 | 3 |
Variants in ITGAX
This is a list of pathogenic ClinVar variants found in the ITGAX region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-31355911-G-A | not specified | Uncertain significance (Jul 26, 2024) | ||
16-31355937-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
16-31355940-G-T | not specified | Uncertain significance (Aug 28, 2024) | ||
16-31355946-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
16-31355950-T-C | not specified | Uncertain significance (Apr 06, 2024) | ||
16-31355958-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
16-31356641-C-T | not specified | Uncertain significance (Jun 30, 2022) | ||
16-31356669-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
16-31356698-A-T | not specified | Uncertain significance (Mar 29, 2023) | ||
16-31356716-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
16-31356723-T-G | not specified | Uncertain significance (Oct 18, 2021) | ||
16-31357043-C-T | not specified | Uncertain significance (May 30, 2023) | ||
16-31357259-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
16-31357272-A-G | not specified | Uncertain significance (Sep 29, 2023) | ||
16-31357350-C-A | not specified | Uncertain significance (Jan 03, 2024) | ||
16-31357350-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
16-31359795-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
16-31359826-C-A | not specified | Uncertain significance (Jul 07, 2024) | ||
16-31359968-G-A | not specified | Likely benign (May 28, 2024) | ||
16-31359992-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
16-31360064-G-C | not specified | Uncertain significance (Aug 20, 2024) | ||
16-31360315-G-A | not specified | Likely benign (Dec 16, 2023) | ||
16-31360330-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
16-31360333-A-G | not specified | Uncertain significance (Apr 22, 2022) | ||
16-31360395-G-T | not specified | Uncertain significance (Jun 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGAX | protein_coding | protein_coding | ENST00000268296 | 30 | 27864 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.37e-15 | 1.00 | 125648 | 0 | 100 | 125748 | 0.000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.553 | 658 | 699 | 0.941 | 0.0000418 | 7583 |
Missense in Polyphen | 258 | 288 | 0.89585 | 3158 | ||
Synonymous | -0.695 | 317 | 302 | 1.05 | 0.0000198 | 2334 |
Loss of Function | 3.39 | 35 | 64.4 | 0.544 | 0.00000330 | 667 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000566 | 0.000566 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000892 | 0.000870 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000327 | 0.000325 |
Middle Eastern | 0.000892 | 0.000870 |
South Asian | 0.000851 | 0.000850 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Integrin alpha-X/beta-2 is a receptor for fibrinogen. It recognizes the sequence G-P-R in fibrinogen. It mediates cell-cell interaction during inflammatory responses. It is especially important in monocyte adhesion and chemotaxis.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Integrin-mediated Cell Adhesion;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;TYROBP Causal Network;Interleukin-4 and 13 signaling;Neutrophil degranulation;Integrin cell surface interactions;Extracellular matrix organization;Innate Immune System;Immune System;Integrin;Cell surface interactions at the vascular wall;Hemostasis;ECM proteoglycans;Beta2 integrin cell surface interactions
(Consensus)
Intolerance Scores
- loftool
- 0.441
- rvis_EVS
- -0.92
- rvis_percentile_EVS
- 9.84
Haploinsufficiency Scores
- pHI
- 0.0986
- hipred
- N
- hipred_score
- 0.214
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.799
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Itgax
- Phenotype
- hematopoietic system phenotype; normal phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell adhesion;integrin-mediated signaling pathway;animal organ morphogenesis;cytokine-mediated signaling pathway;extracellular matrix organization;heterotypic cell-cell adhesion;neutrophil degranulation;leukocyte migration
- Cellular component
- plasma membrane;integrin complex;cell surface;membrane;secretory granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane
- Molecular function
- protein binding;signaling receptor activity;metal ion binding